Applications of the genO‑HSA/hFcRn mouse model

Broad range of applications in the fields of immuno-oncology, infectious diseases and autoimmunity:

  • Assess pharmacokinetics and pharmacodynamics (PK/PD) features, including biodistribution and binding affinity
  • Screen compounds based on extended half-life
  • Assess the efficacy of optimized therapeutics such as Fc-engineered antibodies, constructs fused to HSA, HSA- and/or FcRn-binding proteins or small molecules

Features

  • Physiological expression and distribution of HSA and human FcRn
  • Lack of expression of the murine target genes
  • Higher physiological affinity of human serum albumin to human FcRn
  • Unaltered blood chemistry compared to a wild-type mouse

Related resources and publications

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No results
No results

Validation data

Discover related products to

genO‑HSA/hFcRn

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
HSA
PK/PD
Fc receptor
KO-Rep-Mix

genO‑HSA/hFcRn-RAG1KO

This upgraded, immunocompromised RAG1-/- version of our genO-HSA/hFcRn mouse model allows the assessment of compounds' half-life and anti-tumor efficacy in a human tumor model.

FcgR
Fc receptor

genO‑hFcγR

Preclinical humanized Fc-gamma receptor (genO‑hFcγR) model enabling the assessment of Fc receptor pathways targeted therapies.

Inflammation
IgE
FceR1
Fc receptor
Allergy

genO‑hIgE/hFcεR1

Use the genO‑hIgE/hFcεR1 mouse model to successfully screen for innovative therapeutics for allergy, asthma and other IgE-mediated diseases.

Double-humanized genO‑HSA/hFcRn mouse model

Get in touch about

Let us know how we can help